ME00975B - Aromatizovana terapeutska kompozicija na bazi gline - Google Patents

Aromatizovana terapeutska kompozicija na bazi gline

Info

Publication number
ME00975B
ME00975B MEP-2010-20A MEP2010A ME00975B ME 00975 B ME00975 B ME 00975B ME P2010 A MEP2010 A ME P2010A ME 00975 B ME00975 B ME 00975B
Authority
ME
Montenegro
Prior art keywords
clay
therapeutic composition
flavoured
based therapeutic
aroma
Prior art date
Application number
MEP-2010-20A
Other languages
English (en)
French (fr)
Inventor
Hazif Denis Le
Jérôme Barra
Original Assignee
Ipsen Pharma Sas
Firmenich & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas, Firmenich & Cie filed Critical Ipsen Pharma Sas
Publication of ME00975B publication Critical patent/ME00975B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Predmet predstavljenog pronalaska je aromatizovana terapeutska kompozicija koja sadrži glinu kao aktivni element, i koju karakteriše to što je glina dioktaedarski smektit i što je aroma.
MEP-2010-20A 2007-08-13 2008-08-12 Aromatizovana terapeutska kompozicija na bazi gline ME00975B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07291005A EP2025332A1 (fr) 2007-08-13 2007-08-13 Composition thérapeutique aromatisée à base d'argile
PCT/FR2008/001185 WO2009056703A1 (fr) 2007-08-13 2008-08-12 Composition thérapeutique aromatisée à base d'argile

Publications (1)

Publication Number Publication Date
ME00975B true ME00975B (me) 2012-06-20

Family

ID=39052728

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2010-20A ME00975B (me) 2007-08-13 2008-08-12 Aromatizovana terapeutska kompozicija na bazi gline

Country Status (27)

Country Link
US (2) US20100159013A1 (me)
EP (3) EP2025332A1 (me)
JP (2) JP5670189B2 (me)
KR (2) KR101503957B1 (me)
CN (2) CN101778622A (me)
AR (2) AR067929A1 (me)
BR (1) BRPI0814979A2 (me)
CA (1) CA2696062C (me)
CL (1) CL2008002366A1 (me)
DK (1) DK2194968T3 (me)
EA (1) EA017118B1 (me)
ES (2) ES2421379T3 (me)
GE (1) GEP20125539B (me)
HK (2) HK1143956A1 (me)
HU (1) HUE029713T2 (me)
MA (1) MA31678B1 (me)
ME (1) ME00975B (me)
MX (1) MX2010001533A (me)
NO (1) NO20100114L (me)
PE (1) PE20090939A1 (me)
PL (2) PL2710998T3 (me)
PT (2) PT2194968E (me)
SA (1) SA08290496B1 (me)
TN (1) TN2010000058A1 (me)
TW (2) TWI511734B (me)
UA (1) UA97408C2 (me)
WO (1) WO2009056703A1 (me)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025332A1 (fr) * 2007-08-13 2009-02-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Composition thérapeutique aromatisée à base d'argile
FR2952814B1 (fr) * 2009-11-23 2013-07-19 Ephyla Sas Composition comprenant un complexe de phyllosilicates organiquement modifies generer des emulsions huile dans eau eventuellement a froid
US20130310732A1 (en) 2011-01-12 2013-11-21 Sooft Italia Spa Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions
ITUA20162277A1 (it) * 2016-04-04 2017-10-04 Chemists Res Srl Composizione comprendente diosmectite
CN105902625A (zh) * 2016-05-26 2016-08-31 朱胜利 一种小儿止泻药的服用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707367A (en) * 1984-07-16 1987-11-17 Sunkist Growers, Inc. Solid essential oil flavor composition
AU4635285A (en) * 1984-07-16 1986-02-10 Sunkist Growers, Inc. Solid essential oil flavor composition and method of manufacture
JPH064530B2 (ja) * 1985-02-23 1994-01-19 日本化薬株式会社 親水性基剤
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
AU6701694A (en) * 1993-04-16 1994-11-08 Mccormick & Company, Inc. Encapsulation compositions
FR2770778B1 (fr) * 1997-11-12 2000-05-26 Investigations Therapeutiques Composition pour le traitement des gastro-enterites aigues, procede de fabrication de cette composition et solution de traitement obtenue a partir de cette composition
KR20030050958A (ko) * 2001-12-20 2003-06-25 송우영 디옥타헤드랄 스멕타이트를 유효성분으로 함유하는 항균성외용조성물
US8334007B2 (en) * 2003-03-19 2012-12-18 Firmenich Sa Continuous process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
CN100340235C (zh) * 2004-05-21 2007-10-03 山东绿叶制药有限公司 蒙脱石分散片及其制备工艺
EP1627573A1 (en) * 2004-08-20 2006-02-22 Firmenich Sa A process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
JP2006083071A (ja) * 2004-09-14 2006-03-30 Takasago Internatl Corp 香粧品用固形製剤
WO2007051427A1 (fr) * 2005-11-04 2007-05-10 Zhejiang Hailisheng Pharmaceutical Limited Co. Montmorillonite modifiee, son procede de preparation et ses utilisations
FR2901360A1 (fr) 2006-05-16 2007-11-23 Horiba Abx Sas Soc Par Actions Dispositif de conditionnement pour analyse biologique
EP2025332A1 (fr) * 2007-08-13 2009-02-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Composition thérapeutique aromatisée à base d'argile

Also Published As

Publication number Publication date
KR20140133617A (ko) 2014-11-19
EP2194968A1 (fr) 2010-06-16
CN101778622A (zh) 2010-07-14
NO20100114L (no) 2010-03-10
GEP20125539B (en) 2012-05-25
TWI511734B (zh) 2015-12-11
DK2194968T3 (da) 2013-09-02
ES2582871T3 (es) 2016-09-15
EP2025332A1 (fr) 2009-02-18
US9056055B2 (en) 2015-06-16
CL2008002366A1 (es) 2009-05-29
PT2194968E (pt) 2013-07-25
CA2696062C (fr) 2017-09-05
TWI519303B (zh) 2016-02-01
JP2014208715A (ja) 2014-11-06
HK1143956A1 (en) 2011-01-21
TN2010000058A1 (fr) 2011-09-26
SA08290496B1 (ar) 2012-11-03
CA2696062A1 (fr) 2009-05-07
EP2710998B1 (fr) 2016-04-20
JP5670189B2 (ja) 2015-02-18
WO2009056703A1 (fr) 2009-05-07
US20140377354A1 (en) 2014-12-25
MX2010001533A (es) 2010-03-15
EP2194968B1 (fr) 2013-06-19
JP2010535852A (ja) 2010-11-25
EP2710998A1 (fr) 2014-03-26
UA97408C2 (ru) 2012-02-10
TW201509424A (zh) 2015-03-16
KR101503957B1 (ko) 2015-03-18
EA201070257A1 (ru) 2010-06-30
US20100159013A1 (en) 2010-06-24
ES2421379T3 (es) 2013-09-02
WO2009056703A8 (fr) 2010-03-04
CN104173371A (zh) 2014-12-03
EA017118B1 (ru) 2012-09-28
HK1196271A1 (zh) 2014-12-12
PT2710998T (pt) 2016-07-28
BRPI0814979A2 (pt) 2015-02-03
PL2710998T3 (pl) 2016-11-30
KR20100055460A (ko) 2010-05-26
TW200914034A (en) 2009-04-01
PL2194968T3 (pl) 2013-10-31
AR067929A1 (es) 2009-10-28
PE20090939A1 (es) 2009-07-27
HUE029713T2 (en) 2017-03-28
MA31678B1 (fr) 2010-09-01
AR114148A2 (es) 2020-07-29

Similar Documents

Publication Publication Date Title
HN2008000317A (es) Benzimidazoles sustituidos como inhibidores de cinasa
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
JP2008539179A5 (ja) 殺虫活性物質併用の組み合わせ
BRPI0920909A2 (pt) composições de cuidados pessoais que fornecem sensação fe resfriamento intensificada.
ATE484194T1 (de) Wirkstoffkombinationen
DK2001297T3 (da) Aktivstofkombinationer insekticide egenskaber
DE602006002260D1 (de) Insektenabweisende zusammensetzungen mit verzögerter freisetzung
FR2918570B1 (fr) DIGLYCATION DES AGEs.
AR114148A2 (es) Composición terapéutica saborizada basada en arcilla
ATE518421T1 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
ATE547093T1 (de) Schäumbare mundpflegezusammensetzung
BRPI0818121A2 (pt) diespiro 1,2,4-trioxolano e seus métodos de fabricação e utilização
MX2009006777A (es) Combinaciones de principios activos sinergicas.
MA32461B1 (fr) Dronedarone pour la prevention de cardioversion
DE602006000763D1 (de) Kissenkörper
ATE524488T1 (de) Lysobactinamide
IN2012DN03096A (me)
FI20050453A0 (fi) Ihonhoitokoostumus
UY33134A (es) Profarmacos de [4 [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il] -(1h-pirrolo-piridin-il)-metanonas y sintesis de estos.
BRPI0513495A (pt) salicilato de 4-hepten-2-ila e seu uso como ingrediente de fragráncia
ITMI20052327A1 (it) Lisozima umano ricombinante modificato
ES1059981Y (es) Estructura de barras para fumigar.
ITVI20040105A1 (it) Dolce e procedimento per realizzare tale dolce
FR2920926B1 (fr) Dephaseur actif integre.
ES1060422Y (es) Almohada terapeutica de cascara de alforfon.